5,7-dichlorokynurenic acid has been researched along with Retinal Diseases in 1 studies
5,7-dichlorokynurenic acid: potent antagonist at the N-methyl-D-aspartate receptor-associated glycine binding site
Retinal Diseases: Diseases involving the RETINA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hama, Y | 1 |
| Katsuki, H | 1 |
| Tochikawa, Y | 1 |
| Suminaka, C | 1 |
| Kume, T | 1 |
| Akaike, A | 1 |
1 other study available for 5,7-dichlorokynurenic acid and Retinal Diseases
| Article | Year |
|---|---|
Contribution of endogenous glycine site NMDA agonists to excitotoxic retinal damage in vivo.
Topics: Amidohydrolases; Animals; Cell Death; Dose-Response Relationship, Drug; Drug Interactions; Excitator | 2006 |